PedAM
Pediatric Disease Annotations & Medicines
| Disease | portal hypertension |
| Symptom | C0023890|liver cirrhosis |
| Sentences | 38 |
| PubMedID- 24914368 | Selection of a tips stent for management of portal hypertension in liver cirrhosis: an evidence-based review. |
| PubMedID- 24331694 | Non-invasive assessment of portal hypertension in patients with liver cirrhosis using fibroscan transient elastography. |
| PubMedID- 21802316 | Purpose: to develop a clinically relevant porcine model of liver cirrhosis with portal hypertension by means of hepatic transarterial embolization. |
| PubMedID- 24949616 | Partial splenic embolization is an effective interventional procedure performed in liver cirrhosis complicated with portal hypertension to improve the low platelet count. |
| PubMedID- 21460144 | Methods: spectral doppler sonography of the hepatic vein was performed on 22 consecutive patients who underwent hvpg measurement for portal hypertension with liver cirrhosis. |
| PubMedID- 20653965 | Patent paraumbilical and abdominal subcutaneous veins are found frequently as collaterals in patients due to portal hypertension, mainly associated with liver cirrhosis . |
| PubMedID- 22916658 | portal hypertension and varices in patients with liver cirrhosis. |
| PubMedID- 23855493 | Impaired endothelial function is a major cause of portal hypertension in liver cirrhosis. |
| PubMedID- 25798930 | Objective: to investigate the role of contrast-enhanced ultrasonography (ceus) and doppler ultrasonography (dus) in the diagnosis of severe portal hypertension (ph) in patients with liver cirrhosis (lc). |
| PubMedID- 24775062 | Pathology such as myeloproliferative disorder, liver cirrhosis with portal hypertension, deficiency of natural anticoagulant proteins such as protein c or antithrombin iii as well as hepatocellular carcinoma also could contribute to pvt. |
| PubMedID- 23247799 | 1endoscopic appearance of small bowel lesions related to portal hypertension in patients with liver cirrhosis. |
| PubMedID- 25038804 | Estimation of the severity of portal hypertension in patients with liver cirrhosis is another major use of liver stiffness measurements. |
| PubMedID- 21506350 | An analysis of 115 liver cirrhosis patients with portal hypertension was made to find out which of them had variceal bleeding and high risk of its development. |
| PubMedID- 25543221 | liver cirrhosis with portal hypertension is also associated with the presence of pahs in 1-2% of cases. |
| PubMedID- 22577563 | portal hypertension in liver cirrhosis results from the anatomical changes and the development of contractile element in the liver vascular bed secondary to progressive hepatic fibrosis and formation of regenerative nodules . |
| PubMedID- 24339715 | Severe chronic illness included liver cirrhosis with portal hypertension, new york heart association class iv congestive heart failure, chronic respiratory disease, end-stage renal disease, or an immune-compromised state (e.g., leukemia, lymphoma, or aids). |
| PubMedID- 24820919 | Case background: ascites appears mainly as a consequence of portal hypertension in patients with liver cirrhosis, or can be caused by several other causes, such us congestive heart failure, peritoneal malignancy, or tuberculosis. |
| PubMedID- 26516439 | The american association for the study of liver diseases (aasld) and the european association for the study of the liver (easl) have established guidelines that indicate that liver cirrhosis with portal hypertension is a relative contraindication for hepatic resection because of the high risk liver failure after the operation (14–17). |
| PubMedID- 25374673 | Future therapy of portal hypertension in liver cirrhosis - a guess. |
| PubMedID- 25933224 | liver cirrhosis with portal hypertension is characterized by systemic and splanchnic vasodilatory substances release, especially nitric oxide (no) and prostacyclin 3, which lead to hyperdynamic circulatory status, and further increased mesenteric blood flow and portal inflow. |
| PubMedID- 23547461 | The protective effect of n-acetylcysteine magnesium against liver cirrhosis with portal hypertension in rat. |
| PubMedID- 24757655 | Background/aims: this retrospective study assessed the clinical outcome of a transjugular intrahepatic portosystemic shunt (tips) procedure for managing portal hypertension in koreans with liver cirrhosis. |
| PubMedID- 24400086 | The hemodynamic alteration of portal hypertension in patients with liver cirrhosis contributes to most of the clinical manifestations of the disease: gastrointestinal bleeding, hepatic encephalopathy, ascites and renal failure. |
| PubMedID- 26302944 | Additionally, portal hypertensive enteropathy (phe) associated with portal hypertension in patients with liver cirrhosis has been reported to be a major cause of gastrointestinal bleeding . |
| PubMedID- 23403613 | The only inclusion criterion was the presence of clinical portal hypertension with intrinsic liver cirrhosis. |
| PubMedID- 21827004 | Reconstructed cta images showed that different collateral vessels were developed at the end-stage of chronic liver cirrhosis due to severe portal hypertension. |
| PubMedID- 26159275 | This might explain the pathophysiologic correlation between microbial infections and portal hypertension in patients with liver cirrhosis. |
| PubMedID- 22591184 | Soluble cd163, a marker of kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis. |
| PubMedID- 26370856 | Hypothyroidism enhanced portal hypertension in a patient with alcoholic liver cirrhosis, resulting in the development of ascites. |
| PubMedID- 22957328 | Liver elastography for the diagnosis of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 24502094 | Results: sixteen patients were found to have liver cirrhosis, three of them with portal hypertension. |
| PubMedID- 20652243 | Four patients underwent splenectomy because of liver cirrhosis with portal hypertension and gastroesophageal variceal bleeding. |
| PubMedID- 25888771 | Introduction: esophagogastric varices bleeding is a common complication due to portal hypertension in patients with liver cirrhosis. |
| PubMedID- 22878372 | This is due to the common practice of intermittent clamping of drains, because of a perceived risk of hypotension with free drainage, based on historical experience with paracentesis for transudative ascites due to hypo-albuminaemia and portal hypertension in patients with liver cirrhosis. |
| PubMedID- 25374728 | Variceal bleeding is the major complication of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 25336484 | Contrast-enhanced sonography for quantitative assessment of portal hypertension in patients with liver cirrhosis. |
| PubMedID- 25499848 | Portal hypertensive gastropathy (ghp) is a complication of portal hypertension usually associated with liver cirrhosis. |
| PubMedID- 23452051 | Functional variants of enos and inos genes have no relationship to the portal hypertension in patients with liver cirrhosis. |
Page: 1